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OBJECTIVE—Despite their origins in different germ layers,
pancreatic islet cells share many common developmental fea-
tures with neurons, especially serotonin-producing neurons in
the hindbrain. Therefore, we tested whether these developmental
parallels have functional consequences.
RESEARCH DESIGN AND METHODS—We used transcrip-
tional profiling, immunohistochemistry, DNA-binding analyses,
and mouse genetic models to assess the expression and function
of key serotonergic genes in the pancreas.
RESULTS—We found that islet cells expressed the genes en-
coding all of the products necessary for synthesizing, packaging,
and secreting serotonin, including both isoforms of the serotonin
synthetic enzyme tryptophan hydroxylase and the archetypal
serotonergic transcription factor Pet1. As in serotonergic neu-
rons, Pet1 expression in islets required homeodomain transcrip-
tion factor Nkx2.2 but not Nkx6.1. In b-cells, Pet1 bound to the
serotonergic genes but also to a conserved insulin gene regula-
tory element. Mice lacking Pet1 displayed reduced insulin pro-
duction and secretion and impaired glucose tolerance.
CONCLUSIONS—These studies demonstrate that a common
transcriptional cascade drives the differentiation of b-cells and
serotonergic neurons and imparts the shared ability to produce
serotonin. The interrelated biology of these two cell types has
important implications for the pathology and treatment of diabe-
tes. Diabetes 60:3208–3216, 2011
The shared ability of many neurons and endocrinecells, including the pancreatic islet cells, to importamine precursors, decarboxylate them, and con-centrate the products, provided simple methods to
stain these cells (1) and led some investigators to hy-
pothesize that cells with this capacity (amine precursor
uptake and decarboxylation [APUD]) shared a common
embryonic origin (2). While the common origin hypothesis
for APUD cells has since been disproved, our expanding
knowledge of the function and global gene expression pat-
terns of the neuroendocrine secretory cells has only further
confirmed their remarkable similarities (3–5).
The similarities between neurons and b-cells have an
evolutionary basis. The function of insulin has been con-
served, but the cells producing insulin have evolved (6).
Invertebrates express insulin predominantly in neurons,
while in the chordates, insulin expression has shifted to
visceral endocrine cells of endoderm origin—although even
in mammals, low but detectable neural expression of insulin
has persisted in the central nervous system (7). Further-
more, despite its migration to the pancreas, the vertebrate
b-cell continues to communicate with the central nervous
system, and the autonomic nervous system plays a critical
role in the regulation of insulin secretion (8,9).
Not surprisingly, given their common functions and evo-
lutionary connections, islet cells and neurons also share
many similarities in their development (5). These parallels
are particularly obvious for the serotonergic neurons of the
brainstem and the pancreatic b-cells. The homeodomain
transcription factors Lmx1b, Nkx2.2, and Nkx6.1 form part
of transcriptional cascades required for the formation of
both cell types (5,10). In these cascades, Nkx2.2 drives the
expression of Nkx6.1 and the final differentiation of both
cell types (11,12).
The characteristic products of these cells, serotonin and
insulin, also play conserved and interrelated roles in energy
metabolism (13). Because both cell types share the machin-
ery required to sense changes in extracellular glucose con-
centration, glucose modulates the secretion of both products
(14,15). Once secreted, both molecules serve as signals of
energy sufficiency. In mammals, both serotonin and in-
sulin activate the proopiomelanocortin-expressing neu-
rons in the anorexogenic pathway in the hypothalamus
(16–18). In addition, in worms, flies, and mice, central
serotonin signaling regulates insulin secretion either directly
or indirectly (19–21).
To determine how far the similarities of the pancreatic
b-cells and the serotonergic neurons extend, we tested the
two cell types for additional similarities in their gene ex-
pression program and function. We found that b-cells ex-
press all the key components of the serotonergic program
and that the prototypical serotonergic transcription factor
Pet1 is also involved in the synthesis of insulin in the b-cells.
RESEARCH DESIGN AND METHODS
All studies involving mice were approved by the University of California, San
Francisco, Institutional Animal Care and Use Committee. Mice were housed on
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a 12-h light-dark cycle in a controlled climate. Midday of the day of vaginal plug
discovery was set as embryonic day 0.5.
The Fev2/2 (22), Neurog32/2 (23), Nkx2.22/2 (24), Nkx6.12/2 (11), ePet-
cre (25), pdx1-cre (26), R26R (27), and Z/EG (28) mice have previously been
described. All mice were maintained in the C57BL6 background.
Glucose and insulin tolerance tests were performed on fasting male mice
injected intraperitoneally with glucose (2 g/kg) or insulin (0.75 units/kg). Blood
glucose levels were measured from tail vein blood using the FreeStyle gluc-
ometer (Abbott Diabetes Care, Alameda, CA). Insulinwas assayed using the Ultra
Sensitive Rat Insulin ELISA kit (Crystal Chem, Downers Grove, IL) in serum from
blood obtained from retroorbital plexus at 0 and 30 min after glucose injection.
Cell culture and transfection. Culture and transfection of mouse pancreatic
ductal carcinoma (mPAC) cells and mouse bTC3, aTC1.9, and NIH3T3 cells
were performed as previously described (29). The Min6 b-cell line was main-
tained in Dulbecco’s modified Eagle’s medium supplemented with 15% FBS, 100
units/mL penicillin, 100 g/mL streptomycin, and 71.5 mmol/L b-mercaptoethanol.
For adenovirus experiments, mPAC cells were infected at a multiplicity of in-
fection of 50:1 with adenoviruses encoding the basic helix-loop-helix (bHLH)
transcription factors or control adenovirus encoding b-galactosidase and cul-
tured for 2 days prior to assay for Fev mRNA.
Mouse pancreatic islets were isolated by collagenase digestion and hand-
picked (30). Isolated islets were incubated overnight in RPMI 1640 medium
supplemented with 10% FBS, 100 units/mL penicillin, and 100 mg/mL strepto-
mycin. Prior to secretion studies, media were replaced with the additives in-
dicated and collected after 1 hour for insulin assays using the Ultra Sensitive
Rat Insulin ELISA kit. Protein measurement by Western blot was performed as
previously described (29).
Histological analyses. Harvesting and processing of embryonic and adult
mouse pancreatic tissues were performed as previously described (29). For
adult brain sections, mice were perfused with saline and then 4% paraformal-
dehyde in PBS; brains were removed and cryoprotected in 30% sucrose in PBS
and sectioned (50 mm) on a freezing microtome. Immunostaining was per-
formed overnight at 4°C in PBS containing 1% goat serum (pancreatic tissues)
or 4% goat serum, 2% BSA, and 0.1% Triton X-100 in PBS (brain tissues) (primary
and secondary antisera listed in Supplementary Table 1). Slides were imaged on
a Zeiss Axioskop Microscope or on a Leica TCS SL Confocal Microscope.
In situ hybridization. For RNA in situ hybridization analysis of paraffin
sections (5 mm), adult mouse pancreas was processed, sectioned, and hy-
bridized with digoxigenin-labeled riboprobes as previously described (31).
Digoxigenin-labeled sense and antisense riboprobes were detected with al-
kaline phosphatase–coupled antidigoxigenin antibodies using BM purple
(Boehringer Mannheim) as color substrate. For fluorescent in situ hybridization/
immunohistochemistry analysis, the slides were incubated with fluorescein
isothiocyanate–conjugated anti-digoxigenin antibodies (Roche) followed by
immunohistochemistry. The Fev sense probe gave no significant signal on
mouse pancreas or brain.
RT-PCR. Total RNAwas isolated from tissues and cell lines with the RNeasy kit
(Qiagen, Valencia, CA) and treated with Turbo DNase (Ambion, Austin, TX).
cDNA was synthesized using SuperScript II Reverse Transcriptase (Invitrogen,
Carlsbad, CA). For conventional RT-PCR (Fig. 3A), 25 ng was used per PCR
reaction for 35 cycles for Fev using standard conditions. Real-time PCR assays
were performed as previously described (32). Levels of assayed mRNAs were
normalized to expression levels of mouse b-glucuronidase or b-actin. All oli-
gonucleotide sequences are available on request.
Electromobility shift assays. Single-stranded oligonucleotides were 59-end
labeled using (g-32P)ATP and T4 polynucleotide kinase, annealed to excess
complementary strand, and column purified. Electromobility shift assay (EMSA)
buffers and electrophoresis conditions were as previously described (29), using
500 ng poly(dIdC):poly(dIdC) per 10 mL binding mix. Protein was generated in
vitro with the TNT Coupled Reticulocyte Lysate System (Promega) in 50 mL total
volume from 1 mg DNA; 1 mL (;5 ng protein) of the reaction mix was then used
per binding reaction. Sequences for the coding strands are shown in Fig. 5A.
Chromatin immunoprecipitation assays. bTC3 cells were transfected with
the pBAT16.Pet1-FLAG vector or the control pBAT16 vector with no insert.
pBAT16.Pet1-FLAG contains the mouse Fev cDNA linked in frame at the 39end
to the coding sequence for the FLAG peptide tag and inserted downstream of
the cytomegalovirus immediate early promoter and the first intron of the hu-
man b-globin gene. Forty-eight hours after transfection, cells were formalde-
hyde fixed, washed, and lysed; DNA was purified and sheared; and Pet1-DNA
complexes were precipitated as previously described (29) with anti-FLAG
antibody. Approximately 10 ng immunoprecipitated DNA per reaction was
assayed by PCR for specific promoter fragments.
RESULTS
Serotonergic genes in the islet. To test for the presence
of the serotonergic program in the pancreatic islet, we first
measured the levels of the mRNAs encoding tryptophan
hydroxylases TPH1 and TPH2, the two isoforms of the TPH
enzyme that catalyze the initial and committed step in se-
rotonin synthesis. The brain uses both isoforms, while
nonneuronal tissues such as the gut express predominantly
TPH1 (33). We could detect both mRNAs in the embryonic
mouse pancreas, with a peak in both at embryonic day 18.5
(E18.5), shortly before birth (Fig. 1A). Both mRNAs per-
sisted in the adult islet and could be detected at similar
levels in the b-cell line bTC3 (Supplementary Table 2).
Islet expression was confirmed and localized by immu-
nohistochemistry, which detected serotonin as early as
E9.5 in a few glucagon-positive cells in the dorsal bud but
not in the ventral bud (Supplementary Fig. 1A–G). Sero-
tonin expression was detected in most of the glucagon-
expressing cells at E12.5 (Supplementary Fig. 1H–O). At
E14.5, most of the glucagon-expressing cells coexpressed
serotonin (Supplementary Fig. 2A–D), but few of the insulin-
expressing cells (Supplementary Fig. 2E–H) and none of
the neurogenin3-expressing islet progenitor cells (Supple-
mentary Fig. 2I–L) stained for serotonin. By E18.5, how-
ever, all insulin-expressing cells robustly stained for TPH
and serotonin (Fig. 1B and Supplementary Fig. 3), sup-
porting the conclusion that the peripartum peak in Tph1
mRNA levels (Fig. 1A) predominantly results from in-
duction in b-cells. Isoform-specific antisera (34) detected
both TPH1 and TPH2 by immunohistochemistry (Fig. 1C)
and by Western blot (Fig. 1D) in adult mouse islets.
Embryonic pancreas, adult islets, and the islet cell lines
also expressed the mRNAs encoding all of the remaining
proteins required for completing the synthesis and pack-
aging of serotonin: aromatic L-amino acid decarboxylase
(dopamine decarboxylase, gene name Ddc), vesicular mono-
amine transporter (VMAT)2 (Slc18a2), and the serotonin re-
uptake transporter (Slc6a4) (Supplementary Table 2). These
pancreatic cells also expressed mRNA encoding one of the
serotonin autoreceptors found on serotonergic neurons, Htr1b,
but not mRNA encoding a second closely related autor-
eceptor, Htr1a.
Cells in the pineal gland convert serotonin to melatonin
via a two-step process in which the enzyme arylalkylamine
N-acetyltransferase (AANAT) catalyzes the acetylation of
serotonin to N-acetylserotonin, which is then converted to
melatonin by acetylserotonin O-methytransferase. Because
most inbred laboratory mouse strains carry a mutation
in AANAT (35), we did not attempt to measure melatonin
in mouse islets. Instead, we tested for AANAT mRNA in
human islets but did not detect any significant amount,
although TPH1 and TPH2 mRNA were readily detected
(data not shown).
Expression of Pet1 in the pancreas. We next tested
mice for the expression of the serotonergic E-twenty-six
(ETS) transcription factor Pet1 (gene name Fev) (36),
which is also expressed in some endocrine cells in the gut
(37). Quantitative analysis by real-time RT-PCR revealed
a peak at E14.5 in the expression of the mRNA encoding
Pet1 in the embryonic pancreas and persistent robust ex-
pression in the adult islet (Fig. 2A). In situ hybridization
localized Pet1 mRNA in the central regions of the embry-
onic pancreas at E14.5 (Fig. 2B), as well as in the seroto-
nergic nuclei in the brainstem at E12.5 (Fig. 2C).
In the absence of antisera useful for immunohisto-
chemical analysis of Pet1 expression, we used a line of
transgenic mice in which 40 kb of genomic DNA from the
region upstream of the Pet1 coding sequence controls the
expression of the cre recombinase (ePet-cre mice) (25).
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When crossed with mice carrying the marker gene
ROSA26 loxP-stop-loxP lacZ (R26R) (27), cre recombinase
marks Pet-1–expressing cells and their descendents with
b-galactosidase activity. We found that all insulin and most
glucagon-expressing cells contained b-galactosidase in
double transgenic embryos (Fig. 2D–F). At E14.5, all or
almost all b-galactosidase+ cells also expressed the
homeodomain transcription factors Isl1 (Fig. 2J), Nkx2.2
(Fig. 2K), and Pax6 (Fig. 2L) and many also expressed
pancreatic-duodenal homeobox (Pdx)1 (Fig. 2G–I), HB9,
and Nkx6.1 (data not shown), but no cells coexpressed
b-galactosidase and the proendocrine bHLH transcription
factor neurogenin3 (Fig. 2J–L). In addition, fluorescent in
situ hybridization at E14.5 in the pancreas also localized
Pet1 mRNA to the expression domain of Nkx2.2 (Supple-
mentary Fig. 4A–C). In the adult pancreas, b-galactosidase
was restricted to islet cells (Supplementary Fig. 5A–H).
These data are consistent with the expression of Pet1
specifically in the endocrine lineage in the pancreas.
Interestingly, expression from the gene encoding the
prototypical pancreatic transcription factor Pdx1 has also
been reported in the brain (38). Using a strategy similar to
that for tracing cells expressing the ePet-cre allele, we
found that a Pdx1-cre allele (26) specifically marked se-
rotonergic neurons in the brainstem (39) (Supplementary
Fig. 5I–N) as well as pancreatic lineages.
Regulation of Pet1 expression in the pancreas. To
identify determinants of Pet1 expression in the developing
pancreas, we started by testing the role of the bHLH
transcription factor neurogenin3, which initiates the dif-
ferentiation of islet cells from pancreatic progenitor cells
but is only expressed transiently. Consistent with that
FIG. 1. Expression of TPH and serotonin in the pancreas. A: The relative expression levels of mRNA encoding the two TPHs, Tph1 and Tph2, were
quantified by real-time PCR from RNA isolated from the pancreas of mouse embryos at the ages shown and from adult islets and brain. B: Immu-
nofluorescence staining was performed for serotonin (5-hydroxytryptamine [5-HT], red), TPH (using antiserum recognizing both TPH1 and TPH2
[green]) and insulin (blue) or glucagon (blue) in pancreas harvested from mouse embryos at E18.5. C: Antisera specific to TPH1 or TPH2 (red) were
used to costain the adult pancreas along with insulin (green). D: The isoform-specific antisera to TPH1 and TPH2 were used in a Western blot of
protein extracts of NIH3T3 cells expressing mouse TPH2 (lane 1) or TPH2 fused to the V5 tag from simian virus 5 (lane 2), adult mouse islets
(lane 3), or Min6 mouse insulinoma cells (lane 4). All data points represent means 6 SEM of at least three independent experiments. Scale bars, 25
mm. Additional staining is shown in Supplementary Fig. 1. (A high-quality digital representation of this figure is available in the online issue.)
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transient expression, fluorescent in situ hybridization at
E14.5 localized Fev mRNA in occasional cells expressing
neurogenin3 (Supplementary Fig. 4D–F), while ePet1-cre–
mediated recombination (which takes longer to yield de-
tectable expression) did not (Fig. 2J–L).
Forced expression of neurogenin3 via adenovirus in
the pancreatic progenitor cell line mPAC induced Fev
mRNA transcription (Fig. 3A and B). Interestingly, Fev is
the transcription factor gene most strongly induced in the
neurogenin3-expressing progenitor cells in vivo (32). In ad-
dition, mouse embryos lacking neurogenin3 fail to express
Fev mRNA in the developing pancreas (Fig. 3C). Fev mRNA
similarly depends on Nkx2.2 (Fig. 3D) but not Nkx6.1 (Fig.
3E) or Lmx1b (K. Yang, Y.O., and M.S.G., unpublished data).
Fev2/2 mice. To test the function of Pet1 in the islet, we
examined mice homozygous for a targeted disruption of
the Fev gene (22). At E18.5, pancreas size and both gross
and histological appearances of the pancreata in the Fev2/2
embryos were indistinguishable from their heterozygous
and wild-type littermates. Staining for islet hormones did
not detect any differences in the organization or size of the
islets or in the numbers of the various islet cell types
(Supplementary Fig. 6).
Levels of the mRNAs encoding glucagon, somatostatin,
pancreatic polypeptide, and ghrelin were not significantly
changed in the Fev2/2 embryos, but the mRNAs encoding
the b-cell hormones insulin (Ins1 and Ins2) and islet am-
yloid polypeptide (Iapp) were significantly reduced (Fig.
4A). Consistent with these data, insulin content was also
reduced in the pancreas of Fev2/2 embryos (Fig. 4B).
Glucose metabolism in Fev2/2 mice. As previously de-
scribed, Fev2/2 mice can reach adulthood without any
apparent abnormalities except for behavioral phenotypes
consistent with anxiety and depression (22). The weights
of the Pet1-null animals and their wild-type littermates did
not significantly differ throughout postnatal development
and adulthood (Fig. 4C and data not shown). To assess glu-
cose metabolism more closely, we performed intraperitoneal
glucose tolerance tests at 12 weeks after birth. The adult
Pet1-null animals cleared the glucose load significantly more
slowly than their littermates (Fig. 4D). This defect was not
due to decreased insulin sensitivity, since glucose levels fell
as rapidly in mutant as in wild-type animals in response to
injected insulin (insulin tolerance test [Fig. 4E]).
Instead, the Pet1-null animals displayed a defect in in-
sulin secretion. At 30 min into the glucose tolerance test,
serum insulin levels in the Pet1-null animals rose to ap-
proximately one-half the level in the wild-type littermate
controls (Fig. 4F), despite the higher glucose levels (Fig.
4D). Islets isolated from the adult Fev2/2 animals also
FIG. 2. Expression of serotonergic transcription factor Pet1 in the pancreas. A: Levels of Fev mRNA (encoding Pet1) were quantified by real-time
PCR from RNA isolated from the pancreas and brain of mouse embryos at the ages shown and from adult islets. All data points represent means 6
SEM of at least four independent experiments. B and C: In situ hybridization was performed for Fev in pancreas at E14.5 (B) and brainstem at
E12.5 (C) from mouse embryos. D–L: Immunofluorescence staining was performed for b-galactosidase (blue) in pancreas from ePet1-cre/R26R
mouse embryos at E14.5. Separate color channels are shown for red and green (D and G), red and blue (H), and blue (E). In D and F, most cells
staining with insulin (red) and glucagon (green) costain for b-galactosidase. In G–I, a subset of cells staining for Pdx1 (red) and E-cadherin
(green) costain for b-galactosidase. The b-galactosidase antiserum also costains cells with nuclear staining for Nkx2.2 (green [K]), Isl1 (green
[J]), and Pax6 (green [L]) but not Neurog3 (red [J–L]). Scale bars, 25 mm. in, intestine; pa, pancreas; st, stomach; 3v, 3rd ventricle. Additional
lineage tracing images are shown in Supplementary Fig. 5. (A high-quality digital representation of this figure is available in the online issue.)
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demonstrated a defect in insulin secretion in vitro (Fig.
4G). These defects in insulin secretion correlated with
a decrease in pancreatic insulin content (Fig. 4H) in the
Fev-null animals but not with any deficit in b-cell mass,
which was actually increased in the null animals tested
(Fig. 4I), although the increase did not reach statistical
significance. Therefore, insulin gene expression and in-
sulin production per b-cell are substantially reduced in the
absence of Pet1 in both fetal and adult mice.
To explore the possibility that Pet1 directly targets the
insulin genes, we examined the insulin promoters. The
sequences of the rodent and human insulin gene promoters
contain several potential binding sites for Pet1 with the
consensus core sequence GGAA (40) (Fig. 5A). In an EMSA,
in vitro produced Pet1 protein bound to a labeled oligonu-
cleotide containing the two most proximal GGAA elements
(located at2143 and –132 bp) (Fig. 5B–D), and binding with
mutant probes demonstrated that Pet1 bound to the more
proximal of the two sites (2132 bp) with the highest affinity
(Fig. 5D). This site, previously called GG-I (41), is conserved
in the human and rodent genes and lies adjacent to binding
sites for Nkx2.2 and v-maf musculoaponeurotic fibrosar-
coma oncogene homolog A (MafA) (5). Pet1 binding to this
region of the mouse insulin promoter was also confirmed in
intact b-cells by chromatin immunoprecipitation (Fig. 5E).
Finally, Pet1 activated the human insulin gene promoter
linked to the luciferase reporter gene when expressed in the
pancreatic ductal cell line mPAC L20 (Fig. 5F).
Gene expression in Fev2/2 mice. To determine whether
Pet1 targets other b-cell genes, we looked at the expres-
sion of the genes encoding key components in glucose
sensing in the b-cell. Levels of the mRNAs encoding the
sulfonyl receptor, ATP-sensitive K+ channel and glucoki-
nase (Abcc8, Kcnj11, and Gck, respectively), were not
reduced in the Fev2/2 embryos at E17.5, but Slc2a2 mRNA
encoding Glut2 was reduced (Fig. 6A). Pet1 bound to both
the Gck and Slc2a2 genes in b-cells as assessed by chro-
matin immunoprecipitation (Fig. 6C).
We also tested for changes in the expression of seroto-
nergic genes in the pancreas of the Fev2/2 mice at E18.5.
Surprisingly, we saw no reduction in the levels of any of the
serotonergic mRNAs at E18.5 (Fig. 6B), despite previous
evidence of their regulation by Pet1 in the brainstem (22,36);
this result was confirmed by the normal serotonin immu-
noreactivity in the Fev2/2 pancreas at E18.5 (Supplemen-
tary Fig 7). However, in support of previous in vitro binding
studies (36), Pet1 did bind to the 59 flanking region of each
of these genes in intact b-cells as assessed by chromatin
immunoprecipitation (Fig. 6C). In contrast, the expression
of Tph2, but not the other serotonergic genes, was reduced
in Nkx2.22/2 and Nkx6.12/2 embryos (Fig. 6E and F).
Finally, we measured the expression of genes encoding
multiple islet transcription factors, including many of
those implicated in insulin gene expression. The only
factor significantly reduced (albeit modestly) in expression
in the pancreas at E18.5 in Fev2/2 embryos was Lmx1b
(Fig. 6D), which also plays a role in serotonergic neuron
development downstream of Nkx2.2 (10). Expression of
Lmx1b also depended on Nkx2.2 in the pancreas (Fig. 6E).
DISCUSSION
Similarities in the developmental programs that drive the
differentiation of the serotonergic neurons and pancreatic
b-cells led us to examine whether the b-cells can also
produce serotonin. We found that the b-cells, as well as
some other islet cell types, express all of the genes re-
quired to synthesize, package, and secrete serotonin.
b-Cells express both isoforms of TPH, the enzyme that
catalyzes the rate-limiting step in serotonin synthesis: hy-
droxylation of tryptophan to 5-hydroxytryptophan. Ex-
pression of TPH1 peaks in the neonatal period in the islet. In
addition, b-cells express dopamine decarboxylase, the enzyme
that catalyzes the next (final) step in serotonin synthesis: de-
carboxylation of 5-hydroxytryptophan to 5-hydroxytryptamine
FIG. 3. Regulation of Pet1 in the pancreas. A: The mRNA encoding Pet1
(Fev) was amplified by RT-PCR from RNA isolated from mPAC cells
infected with adenovirus expressing b-galactosidase (Adeno-LacZ) or
human neurogenin3 (Adeno-NEUROG3) and from mouse E15.5 em-
bryonic pancreas. B: The relative expression levels of Fev mRNA were
quantified by real-time PCR from RNA isolated from mPAC cells
infected with adenovirus expressing the proteins shown. C–E: The
relative expression levels of Fev mRNA were quantified by real-time
PCR with pancreas RNA isolated at E18.5 from mouse embryos with
targeted deletions of Neurog3 (C), Nkx2.2 (D), and Nkx6.1 (E). All
data points represent means 6 SEM of at least three independent
experiments. *P < 0.05 vs. heterozygote and vs. wild type (D); **P <
0.01, ***P < 0.001, and ****P < 0.0001 vs. cells infected with adeno-
virus expressing b-galactosidase (B); and ****P < 0.0001 vs. wild type
(C) by two-tailed Student t test. Numerical values of expression level
relative to control are shown above lowest expressing samples. Und.,
undetected. In situ hybridization studies for Fev with immunofluo-
rescent staining for Nkx2.2 and Neurog3 are shown in Supplementary
Fig. 4.
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(serotonin). b-Cells also express VMAT2, the transporter
that loads serotonin into secretory vesicles. Interestingly,
islet cells express very low levels or none of the synapse-
related serotonergic genes SLC6A4 and Htr1a.
The expression of dopamine decarboxylase and the VMATs
gives islet cells the ability to decarboxylate and store mono-
amine precursors and thus the APUD phenotype described
almost 50 years ago (1,2). This capacity to take up and store
serotonin has been exploited by using serotonin as a surro-
gate for insulin secretion (42) and by using ligands of VMAT2
for imaging b-cell mass in vivo (43). Monoamine uptake and
storage are characteristics shared by many neuroendocrine
cells, but since the islet cells also have TPH activity, they can
specifically synthesize, store, and secrete serotonin.
FIG. 4. Glucose metabolism in Fev2/2 mice. A: The relative expression levels of the mRNA shown were quantified by real-time PCR from RNA isolated
from pancreata from Fev+/+ and Fev2/2 mouse embryos at E18.5. B: Insulin content was measured in micrograms per milligram of total protein from
pancreata harvested from mouse embryos with the genotypes shown at E18.5. C: Body weights are shown for 13-week-old adult male mice with the
genotypes shown. D and F: Intraperitoneal glucose tolerance tests were performed by injecting 2 g/kg body wt glucose i.p. at time 0 followed by blood
glucose measurements at the times shown inD in Fev+/+ and Fev2/2mice and serum insulin levels at the times shown in F in 13-week-old male Fev+/+ and
Fev2/2 mice. E: Insulin tolerance test was performed by injection of 0.75 units/kg body wt regular insulin i.p. at time 0 followed by blood glucose
measurements at the times shown in D in 13-week-old male Fev+/+ and Fev2/2 mice. G: Insulin secretion over 1 h was measured from isolated islets from
Fev+/+, Fev+/2, and Fev2/2 mice. Data are expressed as the ratio between islets cultured at 2 and 20 mmol/L glucose or at 5 and 30 mmol/L KCl as in-
dicated. H: Insulin content was measured in micrograms per milligram of total protein from pancreata harvested from mice with the genotypes shown.
I: b-Cell area was measured as the percent of total pancreas area staining for insulin in pancreatic sections from 24-week-old male mice with the
genotypes shown. All data points represent means6 SEMof at least three independent experiments. *P< 0.05, **P< 0.01, ***P< 0.001 vs. wild type in
A,B,D, F, andH; *P< 0.05 vs. combined wild type and heterozygotes inG by two-tailed Student t test. Immunofluorescent staining for islet hormones in
Fev+/+ and Fev2/2 embryos at E18.5 is shown in Supplementary Fig. 6.
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The peak in Tph1 expression in islets that occurs during
the perinatal period may provide one explanation for the
variability in islet serotonin content seen in prior studies.
We and others have also found that islet serotonin content
is higher in females and during pregnancy (44–46). This
variability in serotonin production by islets demonstrates
a form of physiological regulation and suggests a function
for islet serotonin. Given the much higher aggregate pro-
duction and secretion of serotonin by the gut compared
with that of the pancreatic islets, it seems unlikely that
serotonin produced by the islet contributes substantially to
systemic serotonin levels; but secretion by islet cells will
primarily impact local concentrations and therefore could
have autocrine or paracrine effects within the islet during
the perinatal period and pregnancy analogous to the local
effects of serotonin in the breast (47). During pregnancy,
the high levels of serotonin drive b-cell proliferation (46).
Since perinatal b-cells also rapidly proliferate (48,49), se-
rotonin may have similar functions in pregnant and peri-
natal b-cells.
We also found that b-cells and other islet cells express
the serotonergic transcription factor Pet1/Fev. In the pan-
creas, expression of Fev depends on the proendocrine
transcription factor neurogenin3: neurogenin3 induced Fev
expression in vitro, pancreatic Fev expression was lost in
Neurog32/2 embryos, and as we have previously described,
Fev expression is high in the transient neurogenin3-positive
endocrine precursor cells during pancreatic development
(32). This neurogenin3 dependence, together with the in
situ hybridization and lineage tracing data, demonstrates
that Pet1 is expressed specifically in the islet lineage. In
addition, as in the serotonergic neurons (10), Fev expres-
sion in the pancreas requires the downstream target of
neurogenin3, Nkx2.2, but not Nkx6.1 (itself regulated by
Nkx2.2 [24]). Our data from the Fev2/2 animals show,
however, that none of these islet transcription factors de-
pend on Pet1, thus placing Pet1 at the bottom of this cas-
cade of transcription factors, as it is in the serotonergic
neurons as well (10).
In serotonergic neurons, Pet1 drives the expression of
the final differentiation products that characterize the
mature cells, such as serotonergic genes Tph2 and Slc6a4
(22). Surprisingly, in the pancreas Pet1 was not necessary
for Tph2 expression, even though we found that it bound
to Tph2 and other serotonergic genes. In contrast, Tph2
expression in the pancreas did depend on Nkx2.2 and
Nkx6.1, as it does in serotonergic neurons (10).
Instead, our data demonstrate that in the pancreas Pet1
regulates the expression of genes encoding key differenti-
ated b-cell products, including the glucose transporter
gene Slc2a2, Iapp, and both insulin genes. As a result, the
Fev2/2 animals had defects in insulin production and se-
cretion and impaired glucose clearance, despite compen-
satory increases in b-cell mass. Therefore, at the end of the
transcription factor cascade, Pet1 guides the final differen-
tiation and maturation of both serotonergic neurons and
b-cells but does so by regulating overlapping but distinct
sets of genes. It would be interesting to learn what role Pet1
may play in the expression of the b-cell glucose-sensing
genes that are expressed in serotonergic neurons (14,15).
The developmental and functional parallels between the
serotonergic neurons in the brain and the b-cells in the
pancreas may have important practical implications. It
must be kept in mind that pharmacological or genetic
manipulations targeting the serotonergic neurons may in-
advertently impact the b-cells as well—and vice versa. For
example, transgenic strategies using regulatory elements
from the Fev or Pdx1 genes to target either cell type will
likely target both cell types. Since both b-cells and sero-
tonergic neurons regulate glucose metabolism, this genetic
overlap may confound studies of energy homeostasis in
mouse models using these genes for targeting. In addition,
methods developed for generating these cells from stem
cells or other sources must be assessed carefully, since the
overlaps in gene expression profiles may lead to the mis-
identification of the generated cells.
Epidemiologists have long recognized an association be-
tween the risks of type 2 diabetes and depression (50).
Manifold causes likely contribute to this clinical association,
FIG. 5. Pet1 binds to and activates insulin gene promoters. A: The
sequences of oligonucleotides from the human INS (hIns) and mouse
Ins2 (mIns) gene promoters are shown with potential Pet1 binding
sites underlined. Sequences of mutations in two of these sites (m1 and
m2) are shown in boldface. B and D: Double-stranded, radiolabeled
oligonucleotides from A were used to test DNA binding of in vitro
translated proteins by EMSA. The proteins used (in vitro translation
extract alone [-], luciferase [C or control], or Pet1) are shown at the top
of each lane, and the radiolabeled DNA probes used are shown at the
bottom. E: DNA binding by Pet1 was tested in intact cells by chromatin
immunoprecipitation (ChIP). bTC3 cells were transfected with an ex-
pression plasmid with no insert (control) or the Pet1 coding sequence
fused to the FLAG epitope (Pet1-FLAG). Formaldehyde–cross-linked
DNA was precipitated with a-FLAG antibody (Ab), and sequences from
the phosphoenolpyruvate carboxykinase 1 (Pck1) and both of the In-
sulin1 and Insulin2 (Ins) gene promoters were amplified by PCR.
F: Mouse pancreatic ductal mPAC L20 cells were cotransfected with
a DNA plasmid containing the 2362 bp human insulin promoter driving
the expression of luciferase and another expressing the cDNAs shown,
and luciferase activity was assayed and expressed relative to the acti-
vation of the promoterless luciferase vector. **P = 0.0015 vs. no cDNA
by two-tailed Student t test.
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but the genetic and functional similarities of the two key
cell types involved in these diseases strongly suggest that
some genetic or environmental insults may impair both se-
rotonergic neurons and pancreatic b-cells and thus simul-
taneously increase the risk of both depression and type 2
diabetes. In addition, most drugs used to treat psychiatric
disorders affect serotonergic signaling and may therefore
also impact b-cells, especially during periods of high TPH
activity in the islets, such as pregnancy and infancy.
Serotonin and insulin collaborate in an evolutionarily
ancient partnership to regulate our response to changes in
energy availability. Similarities in the function and devel-
opment of the cells that produce serotonin and insulin
reflect this evolutionary connection and have important
implications for energy homeostasis and the pathology and
treatment of diabetes.
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